Comparing Nutraceutical International Corporation (NUTR) & Medifast (MED)
Nutraceutical International Corporation (NASDAQ: NUTR) and Medifast (NYSE:MED) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, analyst recommendations, risk, institutional ownership, profitabiliy and earnings.
This is a breakdown of recent ratings for Nutraceutical International Corporation and Medifast, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Nutraceutical International Corporation||0||0||0||0||N/A|
Medifast has a consensus target price of $36.00, indicating a potential downside of 13.25%. Given Medifast’s higher possible upside, analysts clearly believe Medifast is more favorable than Nutraceutical International Corporation.
This table compares Nutraceutical International Corporation and Medifast’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Nutraceutical International Corporation||5.97%||9.51%||7.00%|
Nutraceutical International Corporation pays an annual dividend of $0.25 per share and has a dividend yield of 0.6%. Medifast pays an annual dividend of $1.28 per share and has a dividend yield of 3.1%. Nutraceutical International Corporation pays out 16.1% of its earnings in the form of a dividend. Medifast pays out 77.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.
Risk & Volatility
Nutraceutical International Corporation has a beta of 0.49, indicating that its share price is 51% less volatile than the S&P 500. Comparatively, Medifast has a beta of 0.48, indicating that its share price is 52% less volatile than the S&P 500.
Earnings and Valuation
This table compares Nutraceutical International Corporation and Medifast’s revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Nutraceutical International Corporation||$239.53 million||1.62||$41.73 million||$1.55||27.00|
|Medifast||$272.81 million||1.81||$40.16 million||$1.65||25.15|
Nutraceutical International Corporation has higher revenue, but lower earnings than Medifast. Medifast is trading at a lower price-to-earnings ratio than Nutraceutical International Corporation, indicating that it is currently the more affordable of the two stocks.
Insider & Institutional Ownership
71.9% of Nutraceutical International Corporation shares are owned by institutional investors. Comparatively, 91.9% of Medifast shares are owned by institutional investors. 13.1% of Nutraceutical International Corporation shares are owned by insiders. Comparatively, 6.5% of Medifast shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Medifast beats Nutraceutical International Corporation on 9 of the 14 factors compared between the two stocks.
About Nutraceutical International Corporation
Nutraceutical International Corporation is an integrated manufacturer, marketer, distributor and retailer of nutritional supplements and other natural products. The Company’s products include vitamins and minerals; herbs; specialty formulas; personal care products; liquid nutritional products; homeopathics; functional foods, and other products. It offers its products to and through domestic health and natural food stores. It acts as a distributor to the Healthy Foods Channel and to certain international markets for certain third-party brands. It manufactures and sells nutritional supplements and other natural products under numerous brands, including Solaray, KAL, Dynamic Health, Nature’s Life, LifeTime, Natural Balance, NaturalCare, Health from the Sun, Pioneer, Nutra BioGenesis, Life-flo, Organix South, Heritage Store and Monarch Nutraceuticals. It owns various natural food markets, such as The Real Food Company, Thom’s Natural Foods, Cornucopia Community Market and Granola’s.
Medifast, Inc. is engaged in the production, distribution and sale of weight loss, weight management and healthy living products, and other consumable health and nutritional products. Medifast product lines include weight loss, weight management, and healthy living meal replacements, snacks, hydration products and vitamins. The Company provides weight loss, weight management and healthy living products and programs through multiple channels of distribution, which include Take Shape For Life; its direct to consumer business unit through its Website and in-house call centers; Franchise Medifast Weight Control Centers, and a national network of physicians. The Company offers a range of weight loss, weight management and healthy products under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by Take Shape For Life, Flavors of Home and Essential 1 brands. The Company also offers a sports nutrition pilot product line, Dual Fuel.
Receive News & Stock Ratings for Nutraceutical International Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutraceutical International Corporation and related stocks with our FREE daily email newsletter.